Melin Eva O, Svensson Ralph, Dereke Jonatan, Hillman Magnus
Diabetes Research Laboratory, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Region Kronoberg, Department of Research and Development, Växjö, Sweden.
Front Psychiatry. 2021 May 11;12:672931. doi: 10.3389/fpsyt.2021.672931. eCollection 2021.
Alexithymia has been linked to cardiovascular disease. The aim was to explore whether the immuno-inflammatory variables galectin-3 binding protein (Gal3BP), soluble (s)CD163 and galectin-3 were independently associated with alexithymia, while controlling for known risk factors for cardiovascular disease, such as depression, anxiety, impaired glycemic control, obesity, smoking, and physical inactivity in patients with type 1 diabetes (T1D). Cross-sectional design. The participants were consecutively recruited from one diabetes out-patient clinic. Alexithymia, depression and anxiety were assessed by self-report instruments. Blood samples, anthropometrics, and blood pressure were collected, supplemented with data from electronic health records. High Gal3BP was defined as ≥3.3 μg/ml, high sCD163 as ≥0.6 μg/ml, high galectin-3 as ≥2.6 ng/ml, impaired glycemic control as HbA1c >70 mmol/mol (>8.6%) and abdominal obesity as waist circumference ≥ 1.02 m for men and ≥ 0.88 m for women. Two hundred and ninety two patients participated (men 56%, aged 18-59 years, alexithymia prevalence 15%). Patients with alexithymia had higher prevalence of depression (34 vs. 6%, < 0.001), anxiety (61 vs. 30%, < 0.001), high Gal3BP levels (39 vs. 17%, = 0.004), high HbA1c levels (46 vs. 24%, = 0.006), and abdominal obesity (29 vs. 15%, = 0.045). Depression [adjusted odds ratio (AOR) 6.5 < 0.001], high Gal3BP levels (AOR 2.4, = 0.035), and age (AOR 0.96, = 0.027) were independently associated with alexithymia. Abdominal obesity (AOR 4.0, < 0.001), high Gal3BP levels (AOR 2.8, = 0.002), and depression (AOR 2.9, = 0.014) were associated with high HbA1c. Abdominal obesity and anxiety were associated [Crude odds ratio (COR) 2.4, = 0.006]. T1D patients with alexithymia had higher prevalence of high Gal3BP levels, depression, impaired glycemic control, anxiety, and abdominal obesity, which are known risk factors for cardiovascular disease. Only high Gal3BP levels, depression, and younger age were independently associated with alexithymia in adult patients with T1D.
述情障碍与心血管疾病有关。本研究旨在探讨免疫炎症变量半乳糖凝集素-3结合蛋白(Gal3BP)、可溶性(s)CD163和半乳糖凝集素-3是否与述情障碍独立相关,同时控制已知的心血管疾病危险因素,如1型糖尿病(T1D)患者的抑郁、焦虑、血糖控制受损、肥胖、吸烟和身体活动不足。采用横断面设计。参与者连续从一家糖尿病门诊招募。通过自我报告工具评估述情障碍、抑郁和焦虑。采集血样、人体测量数据和血压,并补充电子健康记录数据。高Gal3BP定义为≥3.3μg/ml,高sCD163定义为≥0.6μg/ml,高半乳糖凝集素-3定义为≥2.6ng/ml,血糖控制受损定义为糖化血红蛋白(HbA1c)>70mmol/mol(>8.6%),腹部肥胖定义为男性腰围≥1.02m,女性腰围≥0.88m。292名患者参与研究(男性占56%,年龄18 - 59岁,述情障碍患病率为15%)。述情障碍患者的抑郁患病率更高(34%对6%,P<0.001)、焦虑患病率更高(61%对30%,P<0.001)、Gal3BP水平高的患病率更高(39%对17%,P = 0.004)、HbA1c水平高的患病率更高(46%对24%,P = 0.006)以及腹部肥胖患病率更高(29%对15%,P = 0.045)。抑郁[调整优势比(AOR)6.5,P<0.001]、高Gal3BP水平(AOR 2.4,P = 0.035)和年龄(AOR 0.96,P = 0.027)与述情障碍独立相关。腹部肥胖(AOR 4.0,P<0.001)、高Gal3BP水平(AOR 2.8,P = 0.002)和抑郁(AOR 2.9,P = 0.014)与高HbA1c相关。腹部肥胖与焦虑相关[粗优势比(COR)2.4,P = 0.006]。患有述情障碍的T1D患者高Gal3BP水平、抑郁、血糖控制受损、焦虑和腹部肥胖的患病率更高,而这些都是已知的心血管疾病危险因素。在成年T1D患者中,只有高Gal3BP水平、抑郁和较年轻的年龄与述情障碍独立相关。